TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS)

NCT04526951 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Central Retinal Artery Occlusion

Interventions

DRUG: Intravenous injection of Tenecteplase and one dose of placebo tablet
DRUG: One tablet of Acetylsalicylic Acid and one dose of IV placebo

Sponsor

Oslo University Hospital